More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder in 2020.1 However, fewer than 1 in 5 Medicare beneficiaries with an opioid use disorder (OUD) diagnosis received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decrease drastically during the transition of care.2
This Webinar Series has ended. Series presentations and recordings are all included below (search by date/topic). This information is also available on the MOUD Series Web site, hosted by Health Services Advisory Group (HSAG).
This webinar series was a collaboration of all of the Quality Innovation Network-Quality Improvement Organizations and provided strategies, interventions, and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum. This series’ focus was ensuring MOUD treatment within nursing home/hospital care transitions, but was appropriate for all care settings, including nursing homes, clinics and hospital care teams and their partners.
A general certificate of attendance was provided for continuing education/contact hours. Attendees were responsible for determining if this program meets the criteria for licensure or recertification for their discipline.
MOUD Sessions
PAST EVENT | Session 1 - Role of the Emergency Department (ED) Physician in the Treatment of Patients with OUD
Basics & science of addiction and screening & initiating MOUD
Emergency Physicians are active participants in the quest of solutions to identify patients at risk for substance abuse while using reasonable prescribing guidelines to address the legitimate pain reliefs needs of their patients.
Learn how to recognize opioid use disorder, identify withdrawal, and initiate MOUD in the ED.
Speaker: Bobby Redwood, MD, MPH, FACEP
PAST EVENT | Session 2 - Role of the Pharmacist in the Treatment of Patients with OUD
Medication processes, addressing opioid adverse drug events (ADEs), and risk assessment for opioid prescribing.
Speakers:
Kyla Newland, PharmD: Clinical Pharmacist and Account Manager with Mountain Pacific Quality Health
Megan Penner, PharmD, BCPS: Clinical Assistant Professor, L.S. Skaggs College of Pharmacy
Clinical Pharmacist, Mat Su Regional Medical Center
Jon Pouliot, MS, PharmD, BCPS: Associate Professor, Pharmacy and Pharmaceutical Sciences, Lipscomb University
Emergency Medicine Pharmacist, Williamson Medical Center
PAST EVENT | Session 3 - Seamlessly Transitioning Patients on MOUD to Nursing Homes
During this 2-part webinar, you will learn more from key actors that prepare the patient for discharge and communicate effectively with the receiving facility.
Session 3; Part 1: Presentation
PAST EVENT | Session 4 - Seamlessly Transitioning Patients on MOUD to Nursing Homes
Session 4; Part 2: Panel Discussion
A well-planned transition of care ensures health care continuity, avoids preventable poor outcomes among patients with OUD, and co-occurring mental health disorders. Challenges and barriers persist especially during the transfer of patients to nursing homes.
PAST EVENT | Session 5 - Management of Patients on MOUD During the Nursing Home Stay
-
- Dr. Jean Storm, DO, CHCQM, Medical Director, Quality Insights
- Rob Accetta, RPh, BCGP, FASCP, Senior Pharmacist, IPRO
- Debra Wright, RN, BSN, RAC-CT, Quality Improvement Specialist, Quality Insights
PAST EVENT | Session 6 - Management of Patients on MOUD During the Nursing Home Stay
Management of Patients on MOUD During the Nursing Home Stay
Admissions assessment & treatment, addressing stigma, and naloxone training.
Speakers:
- Dr. Jean Storm, DO, CHCQM, Medical Director, Quality Insights
- Jacki Ulishney, PharmD, MHSA, BCPS, Case Management Pharmacist, Mountain Pacific
- Amy Lund Stone, BSN, RN, Project Manager, CA Bridge
- Jennifer Peerbolte, MPA, RN, Program Specialist, Telligen QI Connect
- Debra Wright, RN, BSN, RAC-CT, Quality Improvement Specialist, Quality Insights
On March 10, all QIO partners hosted the sixth session of this series which consists of supporting healthcare providers to ensure MOUD Treatment Through the Care Continuum. During this session, national experts discussed how to successfully implement and/or sustain medication for opioid use disorder during a nursing home stay. They highlighted the importance of providing training on stigma reduction and having naloxone readily available in case of overdose.
-
- Massachusetts Department of Public Health – The Care of Residents with Opioid & Stimulant Use Disorders in Long-Term Care Settings toolkit
PAST EVENT | Session 7 - Sustaining Recovery for Patients on MOUD
Sustaining Recovery for Patients on MOUD
Presentation April 12, 2024 | Past Event
Speakers
- Dr. Ryan Sarver, MD, FAAFP, Adjunct Assistant Professor of Clinical Medicine for Indiana University School of Medicine
- Heather Brandt, Manager, North Dakota Behavioral Health Community Supports
- Jake Reuter, North Dakota Health and Human Services, Administrator
- Lindsay Sarver, Community Health Improvement Strategist
Access the PowerPoint
Access the Event Recording
In this webinar, our guest speakers described how they support people in recovery beyond the walls of the hospital, nursing homes, and Opioid Treatment Programs (OTPs). Attendees learned more about the specific strategies that can be implemented in rural communities and how to coordinate and sustain this support with community partners.
PAST EVENT | Session 8 - May 10, 2024
In this webinar, Dr. Bobby Redwood, shared information about alternatives to opioids (ALTOs) for pain management and how they can support recovery. Dr. Clifford Moy, also described the role of the psychiatrists in the care of people with OUD and co-occurring mental illnesses. During this session, attendees also learned about solutions people in recovery and their loved ones might use in response to stigma in their community.
Access the PowerPoint Presentation
Access the Event Recording
PAST EVENT | Session 9 - June 9 , 2024
Series Wrap Up
Questions? Contact: Tammy Wagner, RN, LSSGB; Great Plains Quality Innovation Network Quality Improvement Advisor, at tammy.wagner@greatplainsqin.org
References:
1 Health and Human Services: Office of Inspector General. Combating the Opioid Epidemic OIG Report. May 18, 2023. Accessed on: August 2, 2023. Available at: https://oig.hhs.gov/reports-and-publications/featured-topics/opioids/
2 Klimas J, Hamilton M, et al. Retention in Opioid Agonist Treatment: A Rapid Review and Meta-Analysis Comparing Observational Studies and Randomized Controlled Trials. August 6, 2021. Available at: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-021-01764-9